[T cell receptor V beta repertoire of locoregional lymphocytes in malignant effusions]

Gan To Kagaku Ryoho. 1995 Sep;22(11):1622-5.
[Article in Japanese]

Abstract

We analyzed the T cell receptor (TCR) V beta repertoire of lymphocytes obtained from patients with malignant effusion treated by locoregional immunotherapy. Polymerase chain reaction using a panel of V beta subfamily specific oligonucleotide primers(V beta 1-20) was employed after reverse transcription of mRNA isolated from the locoregional cells. No major oligoclonality of TCR repertoire was observed in effusion lymphocytes before the treatment. The expression level of V beta 13.1 repertoire was significantly higher in effusion lymphocytes than in peripheral blood lymphocytes before treatment. V beta 20 gene expression increased significantly after locoregional administration of OK-432. It is suggested that TCR V beta 13.1 may be responsible for effusion lymphocytes and TCR V beta 20 for OK-432-related antigenic stimulus.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Immunotherapy
  • Male
  • Middle Aged
  • Picibanil / therapeutic use*
  • Pleural Effusion, Malignant / immunology*
  • Pleural Effusion, Malignant / therapy
  • Polymerase Chain Reaction
  • Receptors, Antigen, T-Cell, alpha-beta / genetics
  • Receptors, Antigen, T-Cell, alpha-beta / immunology*

Substances

  • Antineoplastic Agents
  • Receptors, Antigen, T-Cell, alpha-beta
  • Picibanil